Cutaneous Mucormycosis Clinically Mimicking Necrotizing Fasciitis in a Patient Without Active Immunosuppression Authors: Akın Öğünç İnan, Nursel Yıldız Zengin, Anıl Pehlevan, Ender Ceylan, Güliz Uyar Güleç, Serkan Öncü Published: 2026 ABSTRACT ABSTRACTCutaneous mucormycosis is a rare invasive fungal infection caused by fungi of the order Mucorales. Although it classically occurs in immunocompromised hosts, traumatic or minor cutaneous inoculation may result in infection even in patients without active immunosuppression. Because vascular invasion may lead to rapidly progressive necrosis, cutaneous mucormycosis can clinically resemble necrotizing soft‐tissue infection. A 70‐year‐old man with a history of laryngeal carcinoma in remission and no active immunosuppressive treatment presented with 1 week of progressive pain, swelling, discoloration, and necrotic lesions of the left leg. Necrotizing fasciitis was clinically suspected because of severe pain, extensive hemorrhagic necrosis along the fascia, and deep soft‐tissue involvement; however, no computed tomography or magnetic resonance imaging was performed. Tissue sampling showed broad, pauciseptate hyphae with right‐angle branching on direct microscopy, and fungal culture grew Mucorales species. Liposomal amphotericin B was initiated at 5 mg/kg/day, but treatment was discontinued after serum creatinine increased from 0.81 to 2.5 mg/dL despite hydration. Intravenous posaconazole was started, followed by oral posaconazole delayed‐release tablets after discharge. Therapeutic drug monitoring was not available. Serial debridements, antifungal therapy, and subsequent skin grafting resulted in clinical recovery without relapse during follow‐up. This case highlights that cutaneous mucormycosis may present with necrotizing deep soft‐tissue involvement and clinically mimic necrotizing fasciitis. The case also underlines the need to avoid overstatement of host immune status when advanced age and previous malignancy are present. Early surgical management, tissue‐based mycological diagnosis, and prompt antifungal therapy remain essential; posaconazole is a useful step‐down or salvage option when amphotericin B toxicity limits treatment, but formulation and therapeutic drug monitoring should be considered.Keywords: cutaneous mucormycosis, liposomal amphotericin B, Mucorales, necrotizing fasciitis, necrotizing soft‐tissue infection, posaconazole, therapeutic drug monitoring Introduction Mucormycosis is an uncommon but severe invasive fungal disease caused by molds of the order Mucorales. It is associated with high morbidity and mortality because diagnosis is often delayed and tissue invasion may progress rapidly [1, 2, 3]. The most frequently recognized predisposing conditions include diabetes mellitus, hematologic malignancy, transplantation, neutropenia, corticosteroid exposure, trauma, burns, and other conditions associated with impaired host defense [1, 2, 3]. Cutaneous mucormycosis is the third most common clinical form of mucormycosis after rhino‐orbital‐cerebral and pulmonary disease [1, 2]. In contrast to other forms, primary cutaneous disease may occur after traumatic inoculation of Mucorales spores into disrupted skin and has been reported even in patients without active systemic immunosuppression [1, 3]. The infection may begin with erythema, edema, pain, and violaceous discoloration and may progress to eschar, ulceration, vascular invasion, and extensive tissue necrosis [1, 2]. Necrotizing soft‐tissue infections are life‐ and limb‐threatening infections characterized by necrosis of the subcutaneous tissue, fascia, or muscle [4, 5, 6, 7]. Because cutaneous mucormycosis may extend into deeper tissues and produce rapid necrosis, it can clinically mimic necrotizing fasciitis. We report a case of cutaneous mucormycosis with necrotizing deep soft‐tissue involvement in an elderly patient without active immunosuppressive therapy, emphasizing diagnostic caution, early tissue sampling, surgical management, and antifungal treatment considerations. Case Presentation A 70‐year‐old male patient presented to our outpatient clinic with complaints of pain, discoloration, and swelling in his left leg for the preceding week (Figure 1). Approximately 1 week earlier, he had been chopping wood, although he did not recall a definite penetrating injury or major traumatic event. The patient had a history of laryngeal carcinoma 7 years earlier and was in remission at the time of presentation. He had been under regular follow‐up and had not received recent chemotherapy, radiotherapy, corticosteroids, or other immunosuppressive therapy. He had no known diabetes mellitus or other chronic systemic disease and was not receiving any regular medication. Initial clinical presentation showing a necrotic lesion on the left leg. On initial evaluation, the patient was alert and in good general condition. His body temperature was 36.6°C, blood pressure was 120/70 mmHg, and heart rate was 95 beats/min. Physical examination revealed a necrotic area measuring approximately 5–7 cm on the lateral aspect of the left tibia, with brown‐to‐black discoloration and white cotton‐like lesions. Local temperature and tenderness were increased, and the patient reported severe pain. Crepitus was absent. Laboratory tests showed glucose 115 mg/dL, hemoglobin A1c 6.1%, serum creatinine 0.81 mg/dL, urea 39 mg/dL, C‐reactive protein 244 mg/L, leukocyte count 31.5 × 103/μL with 92.6% polymorphonuclear leukocytes, platelet count 204 × 103/μL, and erythrocyte count 3.87 × 106/μL. Plain radiographs did not show soft‐tissue gas, bone involvement, or other significant pathology. Cross‐sectional imaging with computed tomography or magnetic resonance imaging was not performed. Because of extensive necrosis, severe pain, and concern for a necrotizing soft‐tissue infection, the patient was taken to the operating room by the plastic surgery team for urgent debridement. During surgery, widespread hemorrhagic necrosis was observed along the fascia, with necrotic involvement extending toward adjacent viable tissues. On the basis of clinical and operative assessment, necrotizing fasciitis was suspected; however, the diagnosis was not supported by cross‐sectional imaging, and the case was therefore interpreted cautiously as cutaneous mucormycosis with necrotizing deep soft‐tissue involvement clinically mimicking necrotizing fasciitis. Tissue samples were obtained intraoperatively for direct microscopic examination and culture. The patient had not received recent antibiotic therapy before admission. After intraoperative tissue sampling, empirical ceftriaxone (2 g/day, intravenously) plus clindamycin (600 mg three times daily, intravenously) was initiated because the infection was community‐acquired, the patient had no recent antibiotic exposure, and he was clinically stable without sepsis at presentation. We acknowledge that broader empirical coverage is generally recommended when classical necrotizing fasciitis or severe necrotizing soft‐tissue infection is strongly suspected. Direct microscopic examination of the tissue using lactophenol cotton blue preparation (original magnification, x400) revealed broad, pauciseptate to aseptate blue‐stained hyphae with right‐angle branching (++++) (Figure 2). The blue color reflected uptake of cotton blue dye by fungal cell‐wall chitin. Based on these findings, liposomal amphotericin B was added at a dose of 5 mg/kg/day. Fungal culture subsequently showed growth of Mucorales species (+++), confirming the diagnosis of cutaneous mucormycosis (Figure 3). Because no bacterial growth was detected, antibacterial therapy was discontinued. The patient underwent several surgical debridements during the course of treatment (Figure 4). Lactophenol cotton blue preparation (original magnification, ×400) showing broad, pauciseptate to aseptate blue‐stained hyphae with right‐angle branching. The blue color reflects uptake of cotton blue dye by fungal cell‐wall chitin. Fungal culture demonstrating growth of mucorales species. Serial debridement course showing extensive necrotic soft‐tissue involvement. After 2 weeks of liposomal amphotericin B therapy, renal function deteriorated despite adequate hydration. Serum creatinine increased from 0.81 mg/dL at baseline to 2.5 mg/dL, raising concern for amphotericin B‐associated nephrotoxicity. Liposomal amphotericin B was discontinued, and intravenous posaconazole (300 mg/day) was initiated. During follow‐up, necrotic tissue decreased, granulation tissue increased, inflammatory markers declined, and local signs of infection regressed. At the end of the first month of antifungal therapy, a skin graft procedure was successfully performed by the plastic surgery team (Figure 5). Because there were no signs of active infection at the graft site, the patient was discharged on oral posaconazole delayed‐release tablets. Therapeutic drug monitoring for posaconazole could not be performed because it was not available in our setting. During outpatient follow‐up, the graft was well adapted and functional (Figure 6). Antifungal therapy was discontinued at the third‐month follow‐up visit, and no relapse was observed. Post‐debridement appearance following skin graft surgery. Follow‐up demonstrating a well‐adapted and functional graft. Discussion This case illustrates the diagnostic difficulty created when cutaneous mucormycosis presents with severe pain, rapidly progressive necrosis, and deep soft‐tissue involvement. The patient had no diabetes mellitus, neutropenia, corticosteroid exposure, active malignancy, chemotherapy, or other active immunosuppressive treatment. Nevertheless, the original wording of “immunocompetent” and “without risk factors” was too strong because advanced age and previous laryngeal carcinoma, even in remission, are clinically relevant host‐related factors. For this reason, the case is better described as occurring in a patient without active immunosuppression rather than in a completely risk‐free host. Cutaneous mucormycosis usually follows disruption of the skin barrier, including trauma, burns, surgery, contaminated dressings, or other forms of inoculation [1, 2, 3]. Mucorales are ubiquitous environmental molds, but the key clinical problem is invasive infection rather than simple colonization. Once inoculated into tissue, angioinvasion, thrombosis, and tissue infarction can lead to rapidly progressive necrosis [2, 3]. In our patient, wood cutting may have caused minor unnoticed skin trauma, providing a plausible portal of entry even though no definite penetrating injury was identified. Necrotizing fasciitis and related necrotizing soft‐tissue infections remain primarily clinical and surgical diagnoses. Severe pain, rapid progression, necrosis, systemic inflammation, and operative findings may raise suspicion, but classical intraoperative features such as gray friable fascia, thin dishwater fluid, lack of frank pus, easy blunt dissection, and extensive undermining are often emphasized in clinical descriptions and guidelines [4, 5, 6, 7]. In this case, severe pain and hemorrhagic fascial necrosis prompted clinical suspicion of necrotizing fasciitis. However, cross‐sectional imaging was not performed, and the operative description did not document all classical hallmarks of necrotizing fasciitis. Therefore, the most cautious interpretation is cutaneous mucormycosis with necrotizing deep soft‐tissue involvement clinically mimicking necrotizing fasciitis. Published reports with the same strict clinical pattern–cutaneous mucormycosis presenting with a necrotizing fasciitis or necrotizing soft‐tissue infection phenotype in patients without active immunosuppression–remain limited. In a global systematic review of cutaneous mucormycosis, a large proportion of patients had no underlying disease and trauma was the most frequent route of acquisition; however, necrotizing fasciitis was reported only in a minority of deeply invasive cases [1]. The largest historical series specifically addressing zygomycotic necrotizing fasciitis included 18 cases, of which 15 occurred in immunocompetent patients [8]. In addition, individual cases have been reported in immunocompetent patients after minor trauma and in adults with lower‐limb primary cutaneous mucormycosis clinically diagnosed as necrotizing fasciitis [9, 10]. These reports consistently emphasize traumatic or minor cutaneous inoculation, rapid tissue necrosis, the need for early tissue diagnosis, and combined surgical and antifungal management. Compared with these reports, the present case is notable for advanced age, absence of diabetes or active immunosuppressive therapy, lack of a clearly defined major traumatic event, and successful step‐down therapy with posaconazole delayed‐release tablets. Management of suspected necrotizing soft‐tissue infection generally requires immediate surgical consultation, early debridement, broad‐spectrum empirical antibacterial therapy, and supportive care [4, 5, 6, 7]. Empirical therapy commonly includes broad coverage against gram‐positive, gram‐negative, and anaerobic organisms, together with clindamycin when toxin‐mediated streptococcal or clostridial disease is suspected [5, 6, 7]. In our patient, ceftriaxone plus clindamycin was chosen initially because the infection appeared community‐acquired, there was no recent antibiotic exposure, and he was clinically stable without sepsis. In retrospect, and particularly if classical necrotizing fasciitis is strongly suspected, broader empirical coverage would be more consistent with current recommendations. For mucormycosis, early surgical debridement combined with systemic antifungal therapy is central to management. The global ECMM/MSG guideline supports early complete surgical treatment whenever feasible and liposomal amphotericin B as first‐line therapy [2]. In the present case, liposomal amphotericin B was started promptly at 5 mg/kg/day after direct microscopy suggested Mucorales infection. The need for repeated debridement and later skin grafting was consistent with the extensive necrotic soft‐tissue involvement and the importance of source control in cutaneous mucormycosis. Posaconazole and isavuconazole are important options for step‐down or salvage therapy in mucormycosis when amphotericin B is contraindicated or limited by toxicity [2, 3]. However, posaconazole exposure is formulation dependent. The oral suspension is associated with more variable absorption, whereas delayed‐release tablets and intravenous formulations generally provide more reliable systemic exposure [11]. In this case, liposomal amphotericin B was discontinued because serum creatinine increased to 2.5 mg/dL despite hydration, and treatment was changed to intravenous posaconazole followed by oral posaconazole delayed‐release tablets. Therapeutic drug monitoring is desirable during prolonged posaconazole therapy, particularly for treatment indications, but it was not available in our setting [11, 12]. This report has several limitations. First, no computed tomography or magnetic resonance imaging was performed to define the depth and extent of infection. Second, although the diagnosis of mucormycosis was supported by direct microscopy and fungal culture from tissue samples, histopathological confirmation of tissue invasion was not available. Third, posaconazole therapeutic drug monitoring could not be performed. Finally, the diagnosis of necrotizing fasciitis was based on clinical and operative suspicion rather than complete documentation of all classical intraoperative criteria. These limitations have been incorporated into the revised diagnostic framing of the case. In conclusion, cutaneous mucormycosis can rarely present with necrotizing deep soft‐tissue involvement and clinically mimic necrotizing fasciitis. In patients with rapidly progressive necrotic skin and soft‐tissue lesions, tissue sampling for fungal examination should be performed early, especially when lesions are atypical or fail to fit a purely bacterial pattern. Prompt surgical debridement, early antifungal therapy, careful assessment of host factors, and attention to antifungal toxicity and formulation‐specific pharmacokinetics are essential for improving outcomes. Author Contributions Akın Öğünç İnan: conceptualization, data curation, investigation, project administration, writing – original draft, writing – review and editing. Nursel Yıldız Zengin: data curation, investigation. Anıl Pehlevan: investigation, methodology. Ender Ceylan: investigation, methodology. Güliz Uyar Güleç: conceptualization, investigation, resources. Serkan Öncü: supervision, writing – original draft, writing – review and editing. Funding The authors have nothing to report. Ethics Statement Written informed consent was obtained from the patient for publication of this case report and accompanying images. According to institutional and national regulations, ethics committee approval is not required for single case reports. Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data supporting the findings of this study are available from the corresponding author upon reasonable request. No publicly available datasets were generated or analyzed in this study. References Associated Data Data Availability Statement The data supporting the findings of this study are available from the corresponding author upon reasonable request. No publicly available datasets were generated or analyzed in this study.